Dr. Daniel Cramer, MD

• Obstetrics & Gynecology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard School

  Residency Hospital, 1982

• Boston Hosp-women

  Residency Hospital, 1976

• University Of Michigan Hospitals

  Internship Hospital, 1971

• University Of Colorado School Of Medicine

  Medical School, 1970

• Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility, 2018-07-06

• Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci, 2017-06-15

• Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among nonsmoking women seekingin vitrofertilization, 2012-09-23

• Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium, 2013-03-22

• Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium, 2017-11-15

• Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation,ß1-4 Branching,ß1-6 Branching, anda2-6 Sialylation in Cancer, 2017-11-21

• ABO blood group and incidence of epithelial ovarian cancer, 2010-03-22

• Epithelial-Mesenchymal Transition (EMT) gene variants and Epithelial Ovarian Cancer (EOC) risk, 2015-09-24

• AUTOANTIBODY BIOMARKERS FOR THE DETECTION OF SEROUS OVARIAN CANCER, 2017-04-18

• Serum and follicular fluid organochlorine concentrations among women undergoing assisted reproduction technologies, 2009-07-14

• A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer, 2011-01-22

• Identification of a locus nearULK1associated with progression-free survival in ovarian cancer, 2021-06-23

• Genome-wide significant risk associations for mucinous ovarian carcinoma, 2015-06-15

• rs495139 in theTYMS-ENOSF1Region and Risk of Ovarian Carcinoma of Mucinous Histology, 2018-08-21

• The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: a pooled analysis of 18 case-control studies, 2016-02-03

• The Epidemiology of Endometrial and Ovarian Cancer, 2011-11-25

• Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma, 2009-06-17

• Epidemiologic perspective on immune-surveillance in cancer, 2011-02-01

• Plasmonic Nanoparticle-Based Digital Cytometry to Quantify MUC16 Binding on the Surface of Leukocytes in Ovarian Cancer, 2020-09-10

• Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study, 2014-12-17

• Tubal ligation, hysterectomy, and epithelial ovarian cancer in the New England Case-Control Study, 2013-07-09

• Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus, 2016-09-07

• LIN28Bpolymorphisms influence susceptibility to epithelial ovarian cancer, 2011-04-11

• AUTOANTIBODY PROFILING TO IDENTIFY BIOMARKERS OF KEY PATHOGENIC PATHWAYS IN MUCINOUS OVARIAN CANCER, 2009-11-05

• Predicting circulating CA125 levels among healthy premenopausal women, 2019-04-04

• Identification of twelve new susceptibility loci for different histotypes of epithelial ovarian cancer, 2017-03-27

• Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31, 2013-06-21

• Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins, 2021-02-22

• Puerperal Mastitis: a Reproductive Event of Importance Affecting Anti-Mucin Antibody Levels and Ovarian Cancer Risk, 2013-08-08

• Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiation, 2021-03-12

• Common analgesic use for menstrual pain and ovarian cancer risk, 2021-07-09

• Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers, 2016-05-17

• Polymorphism in theGALNT1Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium, 2010-05-19

• Duarte GALT genotypes are not associated with ovarian cancer risk, 2012-06-29

• Physical activity and semen quality among men attending an infertility clinic, 2010-12-03

• Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival, 2020-07-06

• Differential blood count as triage tool in evaluation of pelvic masses, 2020-06-02

• Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens, 2011-01-19

• A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk, 2018-07-27

• Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms, 2013-12-14

• Analysis of Over 10,000 Cases Finds No Association between Previously-Reported Candidate Polymorphisms and Ovarian Cancer Outcome, 2013-03-19

• Integration of Cell Phone Imaging with Microchip ELISA to Detect Ovarian Cancer HE4 Biomarker in Urine at the Point-of-Care, 2011-09-01

• No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival, 2016-09-27

• Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer, 2016-06-21

• GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer, 2013-06-01

• A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort, 2016-04-08

• Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk, 2015-06-19

• Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk, 2014-07-28

• Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies, 2012-04-01

• Association of Hexachlorobenzene (HCB), Dichlorodiphenyltrichloroethane (DDT), and Dichlorodiphenyldichloroethylene (DDE) within VitroFertilization (IVF) Outcomes, 2011-08-29

• Evaluation of vitamin D biosynthesis and pathway target genes revealsUGT2A1/2andEGFRpolymorphisms associated with epithelial ovarian cancer in African American Women, 2019-04-18

• A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers, 2022-04-21

• Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium, 2010-06-24

• Intrauterine device use and risk of ovarian cancer: results from the New England Case-Control study and Nurses' Health Studies, 2021-03-17

• Estrogen plus progestin hormone therapy and ovarian cancer: a complicated relationship explored, 2020-09-16

• High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival, 2021-11-17

• Co-occurrence of immune-mediated conditions and endometriosis among adolescents and adult women, 2021-02-25

• ESR1/SYNE1polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study, 2010-04-05

• Peripheral blood leukocyte telomere length and endometriosis, 2020-06-23

• Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin, 2013-03-13

• Breast-feeding the last born child and risk of ovarian cancer, 2009-11-10

• History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium, 2017-03-14

• Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study, 2018-03-20

• Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC), 2015-09-15

• Development and validation of circulating CA125 prediction models in postmenopausal women, 2019-11-26

• ABCB1 (MDR1)polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas, 2013-08-01

• Prognostic Significance and Predictors of the Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer, 2014-01-23

• Genetic variation inTYMSin the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium (OCAC), 2010-06-22

• A splicing variant ofTERTidentified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer, 2016-09-16

• A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants, 2019-01-20

• Statin Therapy and Association with Ovarian Cancer risk in the New England Case Control (NEC) Study, 2018-10-30

• Tumor-associated auto-antibodies as early detection markers for ovarian cancer? A prospective evaluation, 2018-03-08

• Menstrual pain and epithelial ovarian cancer risk, 2014-09-05

• PALB2, CHEK2andATMrare variants and cancer risk: data from COGS, 2016-09-05

• Consortium analysis of 7 candidate SNPs for ovarian cancer, 2008-07-15

• Correlates of the pre-operative level of CA125 at presentation of ovarian cancer, 2010-09-17

• Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies, 2017-01-24

• Assessing the genetic architecture of epithelial ovarian cancer histological subtypes, 2016-04-13

• Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness, 2013-01-10

• Periodontal bone loss and risk of epithelial ovarian cancer, 2015-04-03

• Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors, 2018-10-19

• Serum Concentrations of Polychlorinated Biphenyls in Relation toin VitroFertilization Outcomes, 2011-02-24

• Activation of PAF-Receptor and Pleiotropic Effects on Tyrosine Phospho-EGFR/Src/FAK/Paxillin in Ovarian Cancer, 2008-07-15

• Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk, 2016-05-10

• Pooled analysis of the association ofPTGS2rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk, 2010-06-18

• Flavonoid intake and ovarian cancer risk in a population-based case-control study, 2009-04-15

• Genome-wide Association Study of Subtype-Specific Epithelial Ovarian Cancer Risk Alleles Using Pooled DNA, 2013-11-05

• Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk, 2017-02-24

• Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium, 2017-09-21

• A Genome-Wide Association Study Identifies A New Ovarian Cancer Susceptibility Locus On 9p22.2, 2009-08-02

• Point of failure as a predictor ofin vitrofertilization treatment discontinuation, 2008-09-30

• Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer, 2022-02-26

• MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma, 2021-11-15

• Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration, 2016-07-12

• Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk, 2012-01-20

• Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium, 2017-01-03

• Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium, 2019-03-23

• Serum and follicular fluid concentrations of polybrominated diphenyl ethers andin-vitrofertilization outcome, 2012-05-07

• Common variants at 19p13 are associated with susceptibility to ovarian cancer, 2010-09-19

• ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium, 2012-09-08

• Progesterone Receptor Gene Polymorphisms and Risk of Endometriosis: Results from an International Collaborative Effort, 2010-08-17

• CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study, 2022-12-26

• Folate, vitamin B6, vitamin B12, methionine and alcohol intake in relation to ovarian cancer risk, 2011-11-08

• Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk, 2018-12-17

• Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the U.S., 2021-01-18

• Genome-wide Meta-analyses of Breast, Ovarian and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by At Least Two Cancer Types, 2016-07-17

• The role ofKRASrs61764370 in invasive epithelial ovarian cancer: implications for clinical testing, 2011-03-08

• Epigenetic analysis leads to identification ofHNF1Bas a subtype-specific susceptibility gene for ovarian cancer, 2013-11-06

• Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer, 2011-03-17

• A Genome-Wide Association Study Identifies Susceptibility Loci for Ovarian Cancer at 2q31 and 8q24, 2010-09-19

• Breast cancer susceptibility alleles and ovarian cancer risk in two study populations, 2009-02-01

• Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort, 2017-03-20

• Analysis of multiple-cycle data from couples undergoingin vitrofertilization: Methodologic issues and statistical approaches, 2012-06-27

• Cotinine Concentrations in Follicular Fluid as a Measure of Secondhand Tobacco Smoke Exposure in Women UndergoingIn VitroFertilization: Inter-matrix Comparisons with Urine and Temporal Variability, 2011-03-11

• Cis-eQTL Analysis And Functional Validation Of Candidate Susceptibility Genes For High-Grade Serous Ovarian Cancer, 2015-09-22

• Does a woman's educational attainment influence in vitro fertilization outcomes?, 2011-05-24

• Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium, 2015-07-07

• Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies, 2013-03-02

• Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer, 2018-09-20

• Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies, 2010-05-25

• Ovarian cancer risk, ALDH 2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium, 2018-01-21

• MTHFRpolymorphisms in relation to ovarian cancer risk, 2010-08-31

• Coffee Intake, Variants in Genes Involved in Caffeine Metabolism and the Risk of Epithelial Ovarian Cancer, 2008-10-21

• Evidence of Differential Effects of Vitamin D Receptor Variants on Epithelial Ovarian Cancer Risk by Predicted Vitamin D Status, 2014-10-20

• Mumps and ovarian cancer: modern interpretation of an historic association, 2010-06-18

• Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer, 2009-01-09

• Polymorphisms ofMUC16(CA125) andMUC1(CA15.3) in Relation to Ovarian Cancer Risk and Survival, 2014-02-13

• CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations, 2010-10-13

• PALB2,CHEK2andATMrare variants and cancer risk: data from COGS, 2016-09-05

• Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer, 2022-06-23

• Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer andTERT, a Cancer Susceptibility "Hot-Spot”, 2010-07-08

• Ovarian Cancer Early Detection by Circulating CA125 in the context of Anti-CA125 Autoantibody Levels: Results from the EPIC cohort, 2017-12-11

• History of comorbidities and survival of ovarian cancer patients, results from the Ovarian Cancer Association Consortium, 2017-07-09

• Identification of six new susceptibility loci for invasive epithelial ovarian cancer, 2015-01-12

• Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes, 2012-07-24

• Effects of risk factors for ovarian cancer in women with and without endometriosis Efectos de los factores de riesgo del cancer de ovario en mujeres con y sin endometriosis, 2022-09-29

• Large-Scale Evaluation of Common Variation in Regulatory T Cell-Related Genes and Ovarian Cancer Outcome, 2014-01-27

• Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk: Results from the EPIC cohort, 2018-04-16

• MicroRNA Processing and Binding Site Polymorphisms are not Replicated in the Ovarian Cancer Association Consortium, 2011-06-02

• Endometrial Intraepithelial Neoplasia Clinical Correlates and Outcomes, 2011-05-25

• Epidemiologic and biologic correlates of serum HE4 and CA125 in women from the National Health and Nutritional Survey (NHANES)., 2021-01-24

• Multiple independent variants at theTERTlocus are associated with telomere length and risks of breast and ovarian cancer, 2013-05-07

• Single Nucleotide Polymorphisms in theTP53Region and Susceptibility to Invasive Epithelial Ovarian Cancer, 2009-03-10

• Novel missense mutations of theDeleted-in-AZoospermia-Like (DAZL)gene in infertile women and men, 2006-08-02

• Characterization of Cell-Bound CA125 on Immune Cell Subtypes of Ovarian Cancer Patients Using a Novel Imaging Platform, 2021-04-25

• Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium, 2013-01-22